bioRxivImmunologyPreprint
The metabolic program of inflammatory eosinophils accounts for chronic parasite-induced skin-disease
David BarinbergiD, Heidi Sebald, Tobias GoldiD, Baplu RaiiD, Daniel RadtkeiD, Dominik LermiD, David VoehringeriD, Jonathan JantschiD, Stefan J. WirtziD, Alina Ulezko AntonovaiD, Marco ColonnaiD, Christian BogdaniD, Ulrike SchleicheriD
Abstract
Eosinophils exert antimicrobial, cytotoxic and immunoregulatory effects, but their function in cutaneous tissue still remains poorly understood. Here, we used a mouse model of chronic cutaneous leishmaniasis caused by the protozoan parasite Leishmania (L.) mexicana to investigate the function and transcriptomic signature of eosinophils in the skin. In C57BL/6 wild-type mice, L. mexicana infection induced local and systemic eosinophilia that was dependent on type 2 innate lymphoid cells and interleukin-5. Genetic and pharmacological depletion of eosinophils led to complete clinical resolution of disease, which was accompanied by a more pronounced Th1 and M1-like macrophage response. Bioinformatic analyses revealed a novel inflammatory and tissue-specific transcriptional trajectory in skin-infiltrating eosinophils. Skin-imprinted eosinophils strongly expressed the high-affinity glucose transporter 3 (Slc2a3), deprived the environment of glucose and directly impeded the function of Th1 cells. Together, our results demonstrate that disease progression and chronicity of L. mexicana infection is caused by inflammatory eosinophils and linked to their metabolic program. Short SummaryThe authors describe that depletion of eosinophils prevents chronic cutaneous disease caused by Leishmania mexicana. They identify a novel, tissue-specific transcriptomic profile of inflammatory skin eosinophils and demonstrate that skin-imprinted eosinophils show strong glucose uptake and directly repress Th1 responses. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=173 SRC="FIGDIR/small/640104v1_ufig1.gif" ALT="Figure 1"> View larger version (36K): org.highwire.dtl.DTLVardef@3ecd3org.highwire.dtl.DTLVardef@1b1283forg.highwire.dtl.DTLVardef@1c941fdorg.highwire.dtl.DTLVardef@b7c39_HPS_FORMAT_FIGEXP M_FIG C_FIG KEY POINTSO_LIEosinophil accumulation precedes the development of chronic cutaneous leishmaniasis C_LIO_LIEosinophil depletion or IL-5 neutralization lead to clinical cure of the disease C_LIO_LIL. mexicana infection elicits a unique transcriptomic signature of skin eosinophils C_LIO_LISkin eosinophils show a marked uptake of glucose and directly repress Th1 responses C_LI
- organism: mouse
- assay: bulk RNA-seq
- research focus: host-pathogen & immune response
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Oral L-arginine cures arginase 1-dependent chronic cutaneous leishmaniasis by redirecting the T helper cell response
Baplu Rai, David Barinberg, … Ulrike Schleicher·bioRxiv·Sep 23, 2025
- Localized Leishmania major infection causes systemic iron deficiency that can be controlled by oral iron supplementation
S. Banerjee, R. Datta·bioRxiv·Jun 3, 2022
- Leishmania mexicana Promotes Pain-reducing Metabolomic Reprogramming In Cutaneous Lesions
G. Volpedo, T. Oljuskin, … A. R. Satoskar·bioRxiv·Aug 9, 2022
- Cytokine and phenotypic cell profiles in human cutaneous leishmaniasis caused by Leishmania donovani
N. Samaranayake, H. Wijesooriya, N. D. Karunaweera·bioRxiv·Jun 16, 2022
- Acriflavine treatment attenuates inflammatory pathology in cutaneous leishmaniasis independently of parasite control
Erin A. Fowler, Fernanda O. Novais·bioRxiv·Jun 9, 2026
- Different isolates of Leishmania aethiopica elicit distinct effector functions in primary human monocytes
Edward Cruz Cervera, Emebet Adem, … Pascale Kropf·bioRxiv·Feb 26, 2025